Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 47,158 | 40,994 | 49,959 | 19,059 | 4,016 |
Cost of Goods | 418 | 591 | 297 | 5,923 | 33 |
Gross Profit | 46,740 | 40,403 | 49,662 | 13,136 | 3,983 |
Operating Expenses | 99,335 | 85,578 | 79,541 | 65,436 | 56,421 |
Operating Income | -52,177 | -44,584 | -29,582 | -51,377 | -52,405 |
Interest Expense | 18,780 | 14,115 | 13,495 | 12,904 | 5,609 |
Other Income | 55,431 | -102 | -121 | -3 | -2,479 |
Pre-tax Income | -15,526 | -58,801 | -43,198 | -64,284 | -60,493 |
Net Income Continuous | -17,779 | -58,801 | -43,198 | -64,284 | -60,493 |
Net Income | $-17,779 | $-58,801 | $-43,198 | $-64,284 | $-60,493 |
EPS Basic Total Ops | -0.10 | -0.33 | -0.24 | -0.36 | -0.35 |
EPS Basic Continuous Ops | -0.09 | -0.33 | -0.24 | -0.36 | -0.35 |
EPS Diluted Total Ops | -0.10 | -0.33 | -0.24 | -0.36 | -0.35 |
EPS Diluted Continuous Ops | -0.09 | -0.33 | -0.24 | -0.36 | -0.35 |
EBITDA(a) | $-52,043 | $-44,354 | $-29,363 | $-51,185 | $-53,271 |